299 related articles for article (PubMed ID: 10544912)
1. Two distinct mutations cause severe hemophilia B in two unrelated canine pedigrees.
Gu W; Brooks M; Catalfamo J; Ray J; Ray K
Thromb Haemost; 1999 Oct; 82(4):1270-5. PubMed ID: 10544912
[TBL] [Abstract][Full Text] [Related]
2. Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B.
Poort SR; Briët E; Bertina RM; Reitsma PH
Thromb Haemost; 1990 Nov; 64(3):379-84. PubMed ID: 2096489
[TBL] [Abstract][Full Text] [Related]
3. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
[TBL] [Abstract][Full Text] [Related]
4. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
Brooks MB; Gu W; Ray K
J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
[TBL] [Abstract][Full Text] [Related]
5. [Molecular diagnosis of inherited coagulation disorders--sequence analysis of hemophilia B patients with anti-factor IX antibodies].
Tanimoto M; Matsushita T; Takamatsu J; Saito H
Rinsho Byori; 1990 Sep; 38(9):1041-6. PubMed ID: 2232265
[TBL] [Abstract][Full Text] [Related]
6. Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: non-homologous recombination associated with a shortened transcript from whole blood.
Hsu TC; Nakaya SM; Thompson AR
Thromb Haemost; 2007 Feb; 97(2):176-80. PubMed ID: 17264943
[TBL] [Abstract][Full Text] [Related]
7. G244E in the canine factor IX gene leads to severe haemophilia B in Rhodesian Ridgebacks.
Mischke R; Kühnlein P; Kehl A; Langbein-Detsch I; Steudle F; Schmid A; Dandekar T; Czwalinna A; Müller E
Vet J; 2011 Jan; 187(1):113-8. PubMed ID: 20303304
[TBL] [Abstract][Full Text] [Related]
8. Point mutations in four hemophilia B patients from China.
Wang NS; Chen SH; Thompson AR
Thromb Haemost; 1990 Oct; 64(2):302-6. PubMed ID: 2270538
[TBL] [Abstract][Full Text] [Related]
9. Molecular genotyping of the Italian cohort of patients with hemophilia B.
Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
[TBL] [Abstract][Full Text] [Related]
10. Five novel point mutations: two causing haemophilia B and three causing factor X deficiency.
Odom MW; Leone G; De Stefano V; Montiel MM; Boland EJ; Anderson J; Jagadeeswaran P
Mol Cell Probes; 1994 Feb; 8(1):63-5. PubMed ID: 8028609
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
12. Detection of ten new mutations by screening the gene encoding factor IX of Danish hemophilia B patients.
Nielsen LR; Scheibel E; Ingerslev J; Schwartz M
Thromb Haemost; 1995 May; 73(5):774-8. PubMed ID: 7482402
[TBL] [Abstract][Full Text] [Related]
13. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
Wang NS; Zhang M; Thompson AR; Chen SH
Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
[TBL] [Abstract][Full Text] [Related]
14. Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4).
Hamaguchi M; Matsushita T; Tanimoto M; Takahashi I; Yamamoto K; Sugiura I; Takamatsu J; Ogata K; Kamiya T; Saito H
Thromb Haemost; 1991 May; 65(5):514-20. PubMed ID: 1871712
[TBL] [Abstract][Full Text] [Related]
15. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations.
Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C
Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
Matthews RJ; Anson DS; Peake IR; Bloom AL
J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of canine factor IX.
Sugahara Y; Catalfamo J; Brooks M; Hitomi E; Bajaj SP; Kurachi K
Thromb Haemost; 1996 Mar; 75(3):450-5. PubMed ID: 8701406
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis and carrier detection of hemophilia B of Chinese origin.
Lin SW; Shen MC
Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
[TBL] [Abstract][Full Text] [Related]
19. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
